← Back to Search

Nutritional therapy for Mucositis

Phase 2
Waitlist Available
Led By Richard Deming, MD
Research Sponsored by MercyOne Des Moines Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and up to approximately 90 days after randomization

Summary

This trial is testing whether a nutritional therapy can reduce mucositis, improve nutrition, and lessen symptoms during chemo-radiation therapy, potentially resulting in better quality of life.

Eligible Conditions
  • Mucositis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and up to approximately 90 days after randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and up to approximately 90 days after randomization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Development of Oral Mucositis during ChemoRadiation Treatment
Secondary study objectives
Change in Bowel Movements
Development of Dysphagia during ChemoRadiation Treatment

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Nutritional therapyActive Control1 Intervention
Serum-derived bovine immunoglobulin/protein isolate (SBI) 10.0 grams once daily
Group II: PlaceboPlacebo Group1 Intervention
Hydrolyzed gelatin 10.0 grams once daily

Find a Location

Who is running the clinical trial?

MercyOne Des Moines Medical CenterLead Sponsor
4 Previous Clinical Trials
171 Total Patients Enrolled
Richard Deming, MD5.04 ReviewsPrincipal Investigator - MercyOne Des Moines Medical Center
MercyOne Des Moines Medical Center
5Patient Review
I couldn't have more confidence in this doctor. He is kind, understanding, and very intelligent. I would trust him with my life.
~2 spots leftby Nov 2025